Third Rock Ventures LLC launched more than 50 biopharma, device and diagnostic companies with its first four venture capital funds, and with its fifth and largest – the $770m Third Rock Ventures V LP – the VC firm intends to create another 10-12 companies, according to partner and chief operating officer Kevin Gillis.
"Our last fund was launched in October 2016, and if you look historically at our cadence of raising funds, they have been every three years – 2007, 2010, 2013, 2016," Gillis told Scrip. "We began the process of raising Fund V in April and we found the market to be quite receptive
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?